1-3 of 3
Francesca Re, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

Stefano Luminari, MD, Luigi Marcheselli, MSc, Irene Defrancesco, MD, Sara Rattotti, MD, Marina Cesaretti, Marco Frigeni, MD, Roberta Sciarra, MD, Federica Cavallo, MD PhD, Marina Deodato, MD, Maria Giuseppina Cabras, MD, Michele Merli, MD, Angela Ferrari, MD, Francesca Re, MDPhD, Michele Spina, MD, Emanuele Cencini, MD, Ombretta Annibali, MD, Alessandro Pulsoni, MD, Marcia Torresan Delamain, MD, Donato Mannina, MD, Gianluca Gaidano, MD PhD, Caterina Stelitano, MD, Daris Ferrari, MD, Carlo Visco, Francesco Angrilli, MD, Vittoria Tarantino, MD, Luca Arcaini, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 393.
https://doi.org/10.1182/blood-2018-99-115827
Published: 2018
Journal Articles

Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification

Simone Ferrero, MD, Barbero Daniela, Mariella Lo Schirico, Andrea Evangelista, PhD, Annalisa Cifaratti, Daniela Drandi, PhD, Elisa Genuardi, PhD, Daniele Grimaldi, Luigia Monitillo, Gian Maria Zaccaria, PhD, Pietro Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, MD, Claudia Castellino, Vincenzo Pavone, Mario Petrini, PhD MD Prof, Francesca Re, MDPhD, Stefan Hohaus, Gerardo Musuraca, MD, Nicola Cascavilla, MD, Angela Giovanna Congiu, Anna Marina Liberati, MD, Giovannino Ciccone, MD, Umberto Vitolo, Sergio Cortelazzo, MD, Marco Ladetto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 920.
https://doi.org/10.1182/blood-2018-99-114442
Published: 2018
Journal Articles

AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R 2 ) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

John P. Leonard, MD, Marek Trněný, Koji Izutsu, MDPhD, Nathan H. Fowler, MD, Xiaonan Hong, MD, Jun Zhu, Huilai Zhang, MDPhD, Fritz Offner, MD, Adriana Scheliga, MD, Grzegorz S. Nowakowski, MD, Antonio Pinto, MD, Francesca Re, MDPhD, Laura Maria Fogliatto, MD, Phillip Scheinberg, MD, Ian W. Flinn, MD PhD, Cláudia Moreira, MD, David Liu, MDPhD, Stacey Kalambakas, MD, Pierre Fustier, PhD, Chengqing Wu, PhD, John G. Gribben
Journal: Blood
Blood (2018) 132 (Supplement 1): 445.
https://doi.org/10.1182/blood-2018-99-110861
Published: 2018